Pulmonary abnormalities in inflammatory bowel disease

Greenstein, 1976, The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients, Medicine (Baltimore), 55, 401, 10.1097/00005792-197609000-00004 Camus, 1993, The lung in inflammatory bowel disease, Medicine (Baltimore), 72, 151, 10.1097/00005792-199372030-00003 Black, 2007, Thoracic manifestations of inflammatory bowel disease, Chest, 131, 524, 10.1378/chest.06-1074 Storch, 2003, Pulmonary manifestations of inflammatory bowel disease, Inflamm Bowel Dis, 9, 104, 10.1097/00054725-200303000-00004 Tzanakis, 1998, Lung function in patients with inflammatory bowel disease, Respir Med, 92, 516, 10.1016/S0954-6111(98)90301-8 Spira, 1998, Large airway disease associated with inflammatory bowel disease, Chest, 113, 1723, 10.1378/chest.113.6.1723 Mansi, 2000, Bronchial hyperresponsiveness in children and adolescents with Crohn's disease, Am J Respir Crit Care Med, 161, 1051, 10.1164/ajrccm.161.3.9906013 Mahadeva, 2000, Clinical and radiological characteristics of lung disease in inflammatory bowel disease, Eur Respir J, 15, 41, 10.1183/09031936.00.15104100 Kuzniar, 2000, Severe tracheobronchial stenosis in a patient with Crohn's disease, Respir J, 15, 209 Le Roux, 1995, Respiratory manifestation of Crohn's disease. Apropos of a case in an adolescent, Rev Mal Respir, 12, 59 Mahajan, 1997, Ulcerative colitis presenting with bronchiolitis obliterans organizing pneumonia in a pediatric patient, Am J Gastroenterol, 92, 2123 Munck, 1995, Latent pulmonary function abnormalities in children with Crohn's disease, Eur Respir J, 8, 377, 10.1183/09031936.95.08030377 Veloso, 1996, Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients, J Clin Gastroenterol, 23, 29, 10.1097/00004836-199607000-00009 Pascual-Lledo, 1997, Interstitial pneumonitis due to mesalamine, Ann Pharmacother, 31, 499, 10.1177/106002809703100421 Honeybourne, 1994, Mesalazine toxicity, BMJ, 308, 533, 10.1136/bmj.308.6927.533b Tanigawa, 1999, Mesalazine-induced eosinophilic pneumonia, Respiration, 66, 69, 10.1159/000029341 Sviri, 1997, Mesalamine-induced hypersensitivity pneumonitis. A case report and review of the literature, J Clin Gastroenterol, 24, 34, 10.1097/00004836-199701000-00007 Constantinidis, 1976, Letter: Eosinophilic pneumonia: an unusual side effect of therapy with salicylazosulfapyridine, Chest, 70, 315, 10.1378/chest.70.2.315 Scherpenisse, 1988, Olsalazine as an alternative therapy in a patient with sulfasalazine-induced eosinophilic pneumonia, J Clin Gastroenterol, 10, 218, 10.1097/00004836-198804000-00024 Cazzadori, 1985, Salazopyrin-induced eosinophilic pneumonia, Respiration, 47, 158, 10.1159/000194762 Sesin, 1998, Mesalamine-associated pleural effusion with pulmonary infiltration, Am J Health Syst Pharm, 55, 2304, 10.1093/ajhp/55.21.2304 Trisolini, 2000, Eosinophilic pleural effusion due to mesalamine. Report of a rare occurrence, Sarcoidosis Vasc Diffuse Lung Dis, 17, 288 Boyd, 1990, Fibrosing alveolitis due to sulphasalazine in a patient with rheumatoid arthritis, Br J Rheumatol, 29, 222, 10.1093/rheumatology/29.3.222 Lazaro, 1997, Mesalamine-induced lung disease, Arch Intern Med, 157, 462, 10.1001/archinte.1997.00440250122018 Williams, 1982, Fibrosing alveolitis, bronchiolitis obliterans, and sulfasalazine therapy, Chest, 81, 766, 10.1378/chest.81.6.766 Davies, 1974, Fibrosing alveolitis and treatment with sulphasalazine, Gut, 15, 185, 10.1136/gut.15.3.185 Leino, 1991, Sulphasalazine-induced reversible hypersensitivity pneumonitis and fatal fibrosing alveolitis: report of two cases, J Intern Med, 229, 553, 10.1111/j.1365-2796.1991.tb00396.x Wang, 1984, Pulmonary infiltrates and eosinophilia associated with sulfasalazine, Mayo Clin Proc, 59, 343, 10.1016/S0025-6196(12)61431-1 Welte, 1991, Mesalazine alveolitis, Lancet, 338, 1273, 10.1016/0140-6736(91)92140-W Sigvaldason, 1983, Interstitial pneumonia due to sulfasalazine, Eur J Respir Dis, 64, 229 Parry, 2002, Sulphasalazine and lung toxicity, Eur Respir J, 19, 756, 10.1183/09031936.02.00267402 Nagy, 2007, A case of interstitial pneumonitis in a patient with ulcerative colitis treated with azathioprine, World J Gastroenterol, 13, 316, 10.3748/wjg.v13.i2.316 Ananthakrishnan, 2007, Severe pulmonary toxicity after azathioprine/6-mercaptopurine initiation for the treatment of inflammatory bowel disease, J Clin Gastroenterol, 41, 682, 10.1097/01.mcg.0000225577.81008.ee Bedrossian, 1984, Azathioprine-associated interstitial pneumonitis, Am J Clin Pathol, 82, 148, 10.1093/ajcp/82.2.148 Cohen, 1971, Pneumocystitis carinii pneumonia: percutaneous lung biopsy and review of literature, Chest, 60, 195, 10.1378/chest.60.2.195 Cohen, 1971, Pneumocystitis carinii pneumonia: percutaneous lung biopsy and review of literature, Chest, 60, 195, 10.1378/chest.60.2.195 Majoor, 2004, Mycobacterium xenopi infection in an immunosuppressed patient with Crohn's disease, Thorax, 59, 631, 10.1136/thx.2003.010546 Imokawa, 2000, Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients, Eur Respir J, 15, 373, 10.1034/j.1399-3003.2000.15b25.x Kaneko, 2006, Pneumocystis jiroveci pneumonia associated with low-dose methotrexate treatment for rheumatoid arthritis: report of two cases and review of the literature, Mod Rheumatol, 16, 36, 10.1007/s10165-005-0443-5 White, 2004, Drug-induced pulmonary infection, Clin Chest Med, 25, 179, 10.1016/S0272-5231(03)00134-5 Iikuni, 2006, Evaluation of Pneumocystic pneumonia infection risk factors in patients with connective tissue disease, Mod Rheumatol, 16, 282, 10.1007/s10165-006-0502-6 di Girolamo, 1998, Cavitary lung tuberculosis in a rheumatoid arthritis patient treated with low-dose methotrexate and steroid pulse therapy, Br J Rheumatol, 37, 1136, 10.1093/rheumatology/37.10.1136 Ebeo, 2003, Methotrexate-induced pulmonary lymphoma, Chest, 123, 2150, 10.1378/chest.123.6.2150 Curtis, 2007, Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists, Arthritis Rheum, 56, 1125, 10.1002/art.22504 Winthrop, 2006, Serious infections with antirheumatic therapy: are biologicals worse?, Ann Rheum Dis, 65, iii54, 10.1136/ard.2006.058503 Keane, 2001, Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent, N Engl J Med, 345, 1098, 10.1056/NEJMoa011110 Winthrop, 2006, Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor, Nat Clin Pract Rheumatol, 2, 602, 10.1038/ncprheum0336 Imaizumi, 2006, Pulmonary infectious complications associated with anti-TNFalpha therapy (infliximab) for rheumatoid arthritis, Intern Med, 45, 685, 10.2169/internalmedicine.45.1623 Kaur, 2007, Pneumocystis jiroveci (carinii) pneumonia after infliximab therapy: a review of 84 cases, Dig Dis Sci, 52, 1481, 10.1007/s10620-006-9250-x Wood, 2003, Histoplasmosis after treatment with anti-tumor necrosis factor-alpha therapy, Am J Respir Crit Care Med, 167, 1279, 10.1164/rccm.200206-563OC Lee, 2002, Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept, Arthritis Rheum, 46, 2565, 10.1002/art.10583 Nakelchik, 2002, Reactivation of histoplasmosis after treatment with infliximab, Am J Med, 112, 78, 10.1016/S0002-9343(01)00945-7 Dweik, 2007, Coccidioidomycosis pneumonia in a nonendemic area associated with infliximab, South Med J, 100, 517, 10.1097/01.smj.0000242797.49218.44 Morelli, 2000, Does administration of infliximab increase susceptibility to listeriosis?, Am J Gastroenterol, 95, 841, 10.1111/j.1572-0241.2000.01872.x Kesteman T, Yombi JC, Gigi J, Durez P, Listeria infections associated with infliximab: case reports. Clin Rheumatol. doi:10.1007/s10067-007-0660-8. Geraghty, 2007, Overwhelming parasitemia with Plasmodium falciparum infection in a patient receiving infliximab therapy for rheumatoid arthritis, Clin Infect Dis, 44, e82, 10.1086/515402 Warris, 2001, Invasive pulmonary aspergillosis associated with infliximab therapy, N Engl J Med, 344, 1099, 10.1056/NEJM200104053441415 Alderson, 2005, Disseminated aspergillosis following infliximab therapy in an immunosuppressed patient with Crohn's disease and chronic hepatitis C: a case study and review of the literature, MedGenMed, 7, 7 Shrestha, 2004, Pneumonia due to Cryptococcus neoformans in a patient receiving infliximab: possible zoonotic transmission from a pet cockatiel, Respir Care, 49, 606 Stack, 2001, Nocardia asteroides lung abscess in acute ulcerative colitis treated with cyclosporine, Am J Gastroenterol, 96, 2255, 10.1111/j.1572-0241.2001.03971.x Kuzela, 1999, Pulmonary complications in patients with inflammatory bowel disease, Hepatogastroenterology, 46, 1714 Johnson, 1978, Pulmonary function in inflammatory bowel disease, Digestion, 18, 416, 10.1159/000198228 Godet, 1997, Pulmonary function abnormalities in patients with ulcerative colitis, Am J Gastroenterol, 92, 1154 Heatley, 1982, Pulmonary function abnormalities in patients with inflammatory bowel disease, Q J Med, 51, 241 Herrlinger, 2002, Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission, Am J Gastroenterol, 97, 377, 10.1111/j.1572-0241.2002.05473.x Douglas, 1989, Respiratory impairment in inflammatory bowel disease: does it vary with disease activity?, Respir Med, 83, 389, 10.1016/S0954-6111(89)80070-8 Pasquis, 1981, Transient pulmonary impairment during attacks of Crohn's disease, Respiration, 41, 56, 10.1159/000194359 Ceyhan, 2003, Bronchial hyperreactivity and allergic status in inflammatory bowel disease, Respiration, 70, 60, 10.1159/000068407 Louis, 1995, Increased frequency of bronchial hyperresponsiveness in patients with inflammatory bowel disease, Allergy, 50, 729, 10.1111/j.1398-9995.1995.tb01214.x Rickli, 1994, Severe inflammatory upper airway stenosis in ulcerative colitis, Eur Respir J, 7, 1899, 10.1183/09031936.94.07101899 Butland, 1981, Chronic bronchial suppuration and inflammatory bowel disease, Q J Med, 50, 63 Kirsner, 1982, Recent developments in “nonspecific” inflammatory bowel disease (first of two parts), N Engl J Med, 306, 775, 10.1056/NEJM198204013061304 Cohen, 1999, Bronchiectasis in systemic diseases, Chest, 116, 1063, 10.1378/chest.116.4.1063 Higenbottam, 1980, Bronchial disease in ulcerative colitis, Thorax, 35, 581, 10.1136/thx.35.8.581 Ward, 1999, Constrictive bronchiolitis and ulcerative colitis, Can Respir J, 6, 197, 10.1155/1999/392575 Desai, 1989, Diffuse panbronchiolitis preceding ulcerative colitis, Chest, 95, 1342, 10.1378/chest.95.6.1342 Kraft, 1976, Unexplained bronchopulmonary disease with inflammatory bowel disease, Arch Intern Med, 136, 454, 10.1001/archinte.1976.03630040056012 Hilling, 1994, Unusual pulmonary complication of ulcerative colitis with a rapid response to corticosteroids: case report, Gut, 35, 847, 10.1136/gut.35.6.847 Vandenplas, 1998, Granulomatous bronchiolitis associated with Crohn's disease, Am J Respir Crit Care Med, 158, 1676, 10.1164/ajrccm.158.5.9801070 Haralambou, 2001, Bronchiolitis obliterans in a patient with ulcerative colitis receiving mesalamine, Mt Sinai J Med, 68, 384 Veloso, 1994, Bronchiolitis obliterans in ulcerative colitis, J Clin Gastroenterol, 19, 339, 10.1097/00004836-199412000-00019 Hotermans, 1996, Nongranulomatous interstitial lung disease in Crohn's disease, Eur Respir J, 9, 380, 10.1183/09031936.96.09020380 Meadway, 1974, Ulcerative colitis, colitic spondylitis and associated apical pulmonary fibrosis, Proc R Soc Med, 67, 324 McKee, 1983, Severe interstitial pulmonary fibrosis in a patient with chronic ulcerative colitis, Am J Gastroenterol, 78, 86 Teague, 1985, Desquamative interstitial pneumonitis complicating inflammatory bowel disease of childhood, J Pediatr Gastroenterol Nutr, 4, 663, 10.1097/00005176-198508000-00030 Balestra, 1988, Ulcerative colitis and steroid-responsive, diffuse interstitial lung disease, JAMA, 260, 62, 10.1001/jama.1988.03410010070037 McCulloch, 1985, Severe steroid responsive pneumonitis associated with pyoderma gangrenosum and ulcerative colitis, Thorax, 40, 314, 10.1136/thx.40.4.314 Treiber, 2000, Mycophenolate mofetil for therapy-resistant interstitial lung disease associated with ulcerative colitis, Am J Gastroenterol, 95, 3674, 10.1111/j.1572-0241.2000.03415.x Sargent, 1985, Pulmonary vasculitis complicating ulcerative colitis, South Med J, 78, 624, 10.1097/00007611-198505000-00031 senberg, 1968, Pulmonary vasculitis—an uncommon complication of ulcerative colitis. Report of a case, N Engl J Med, 279, 1376, 10.1056/NEJM196812192792506 Forrest, 1975, Pulmonary vasculitis and ulcerative colitis, Am J Dig Dis, 20, 482, 10.1007/BF01070795 Collins, 1979, Pulmonary vasculitis complicating childhood ulcerative colitis, Gastroenterology, 77, 1091, 10.1016/S0016-5085(79)80083-9 Kedziora, 1975, Limited form of Wegener's granulomatosis in ulcerative colitis, Am J Roentgenol Radium Ther Nucl Med, 125, 127, 10.2214/ajr.125.1.127 Stebbing, 1999, Pulmonary manifestations of ulcerative colitis mimicking Wegener's granulomatosis, J Rheumatol, 26, 1617 Yano, 2002, A limited form of Wegener's granulomatosis with bronchiolitis obliterans organizing pneumonitis-like variant in an ulcerative colitis patient, Intern Med, 41, 1013, 10.2169/internalmedicine.41.1013 Prekates, 2002, Churg–Strauss syndrome occurring 30 years after the onset of ulcerative colitis, Respir Care, 47, 167 Wechsler, 1980, Crohn's disease associated with Wegener's granulomatosis, Gastroenterol Clin Biol, 4, 356 Tupler, 1991, Wegener granulomatosis of the colon: CT and histologic correlation, J Comput Assist Tomogr, 15, 314, 10.1097/00004728-199103000-00025 Temmesfeld-Wollbrueck, 1997, Granulomatous gastritis in Wegener's disease: differentiation from Crohn's disease supported by a positive test for antineutrophil antibodies, Gut, 40, 550, 10.1136/gut.40.4.550 Haworth, 1984, Severe intestinal involvement in Wegener's granulomatosis, Gut, 25, 1296, 10.1136/gut.25.11.1296 McNabb, 1982, Small intestinal perforation in Wegener's granulomatosis, Postgrad Med J, 58, 123, 10.1136/pgmj.58.676.123 Geraghty, 1986, Intestinal perforation in Wegener's granulomatosis, Gut, 27, 450, 10.1136/gut.27.4.450 Tokuda, 1989, Small intestinal perforation in Wegener's granulomatosis, J Rheumatol, 16, 547 Sokol, 1984, An unusual presentation of Wegener's granulomatosis mimicking inflammatory bowel disease, Gastroenterology, 87, 426, 10.1016/0016-5085(84)90724-8 Camilleri, 1983, Gastrointestinal manifestations of systemic vasculitis, Q J Med, 52, 141 Wakefield, 1991, Granulomatous vasculitis in Crohn's disease, Gastroenterology, 100, 1279, 10.1016/0016-5085(91)90779-K Hardarson, 1993, Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases. High prevalence in ulcerative colitis, primary sclerosing cholangitis, and autoimmune hepatitis, Am J Clin Pathol, 99, 277, 10.1093/ajcp/99.3.277 Rump, 1990, A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease, Immunobiology, 181, 406, 10.1016/S0171-2985(11)80509-7 Sanjeevi, 2003, Necrobiotic nodules: a rare pulmonary manifestion of Crohn's disease, Am J Gastroenterol, 98, 941, 10.1111/j.1572-0241.2003.07365.x Faller, 2000, Pulmonary migratory infiltrates and pachypleuritis in a patient with Crohn's disease, Respiration, 67, 459, 10.1159/000029550 Patwardhan, 1983, Pleuropericarditis: an extraintestinal complication of inflammatory bowel disease. Report of three cases and review of literature, Arch Intern Med, 143, 94, 10.1001/archinte.1983.00350010098017 Orii, 2001, Pleuropericarditis and disseminated intravascular coagulation in ulcerative colitis, J Clin Gastroenterol, 32, 251, 10.1097/00004836-200103000-00017 Stajer, 1996, Myopericarditis, pleuritis and deep venous thrombosis in ulcerative colitis masquerading as pulmonary embolism, Intensive Care Med, 22, 1134, 10.1007/BF01699245 Karmy-Jones, 1995, Colobronchial fistula due to Crohn's disease, Ann Thorac Surg, 60, 446, 10.1016/0003-4975(95)00207-2 Mera, 1996, Crohn's disease associated with colo-bronchial fistula, Intern Med, 35, 957, 10.2169/internalmedicine.35.957 Domej, 1990, Colobronchial fistula: a rare complication of Crohn's colitis, Am Rev Respir Dis, 142, 1225, 10.1164/ajrccm/142.5.1225 Singh, 1994, Colobronchial fistula: an unusual complication of Crohn's disease, Am J Gastroenterol, 89, 2250 Leichtling, 1962, Granulomatous colitis complicated by gastrocolic, duodenocolic, and colopulmonic fistulas, Gastroenterology, 43, 151, 10.1016/S0016-5085(19)35038-3 Gumbo, 2001, Recurrent pneumonia from an ileobronchial fistula complicating Crohn's disease, J Clin Gastroenterol, 32, 365, 10.1097/00004836-200104000-00021 Ghahremani, 1982, Esophageal manifestations of Crohn's disease, Gastrointest Radiol, 7, 199, 10.1007/BF01887639 Cynn, 1975, Crohn's disease of the esophagus, Am J Roentgenol Radium Ther Nucl Med, 125, 359, 10.2214/ajr.125.2.359 Steel, 1988, Cervical Crohn's disease with oesophago-pulmonary fistula, Postgrad Med J, 64, 706, 10.1136/pgmj.64.755.706 Bewig, 1999, Crohn's disease mimicking sarcoidosis in bronchoalveolar lavage, Respiration, 66, 467, 10.1159/000029413 Smiejan, 1986, Sarcoid-like lymphocytosis of the lower respiratory tract in patients with active Crohn's disease, Ann Intern Med, 104, 17, 10.7326/0003-4819-104-1-17 Yee, 2001, Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy, Ann Intern Med, 135, 27, 10.7326/0003-4819-135-1-200107030-00010 Alrashid, 2001, Crohn's disease involving the lung: resolution with infliximab, Dig Dis Sci, 46, 1736, 10.1023/A:1010665807294 Yang, 2000, Alpha1-antitrypsin deficiency and inflammatory bowel diseases, Mayo Clin Proc, 75, 450, 10.1016/S0025-6196(11)64212-2 Elzouki, 1999, The prevalence and clinical significance of alpha 1-antitrypsin deficiency (PiZ) and ANCA specificities (proteinase 3, BPI) in patients with ulcerative colitis, Inflamm Bowel Dis, 5, 246, 10.1097/00054725-199911000-00002 Bernstein, 2001, The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study, Thromb Haemost, 85, 430, 10.1055/s-0037-1615600 Talbot, 1986, Vascular complications of inflammatory bowel disease, Mayo Clin Proc, 61, 140, 10.1016/S0025-6196(12)65200-8 Novacek, 1999, Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease, Am J Gastroenterol, 94, 685, 10.1111/j.1572-0241.1999.00937.x Koutroubakis, 2000, Role of thrombotic vascular risk factors in inflammatory bowel disease, Dig Dis, 18, 161, 10.1159/000051389 Quera, 2004, Thromboembolism—an important manifestation of inflammatory bowel disease, Am J Gastroenterol, 99, 1971, 10.1111/j.1572-0241.2004.40923.x Papa, 2003, Review article: inherited thrombophilia in inflammatory bowel disease, Am J Gastroenterol, 98, 1247, 10.1111/j.1572-0241.2003.07491.x Solem, 2004, Venous thromboembolism in inflammatory bowel disease, Am J Gastroenterol, 99, 97, 10.1046/j.1572-0241.2003.04026.x Aichbichler, 1999, Anti-cardiolipin antibodies in patients with inflammatory bowel disease, Dig Dis Sci, 44, 852, 10.1023/A:1026646816672 Oldenburg, 2000, Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications?, Am J Gastroenterol, 95, 2825, 10.1111/j.1572-0241.2000.03193.x Bernstein, 2005, The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study, Gastroenterology, 129, 827, 10.1053/j.gastro.2005.06.021 Kanazawa, 2005, A case-control study of bronchial asthma associated with ulcerative colitis: role of airway microvascular permeability, Clin Exp Allergy, 35, 1432, 10.1111/j.1365-2222.2005.02358.x